2ijo: Difference between revisions

No edit summary
No edit summary
Line 4: Line 4:


==Overview==
==Overview==
Pathogenic members of the flavivirus family, including West Nile Virus, (WNV) and Dengue Virus (DV), are growing global threats for which there, are no specific treatments. The two-component flaviviral enzyme NS2B-NS3, cleaves the viral polyprotein precursor within the host cell, a process, that is required for viral replication. Here, we report the crystal, structure of WNV NS2B-NS3pro both in a substrate-free form and in complex, with the trypsin inhibitor aprotinin/BPTI. We show that aprotinin binds in, a substrate-mimetic fashion in which the productive conformation of the, protease is fully formed, providing evidence for an "induced fit", mechanism of catalysis and allowing us to rationalize the distinct, substrate specificities of WNV and DV proteases. We also show that the, NS2B cofactor of WNV can adopt two very distinct conformations and that, this is likely to be a general feature of flaviviral proteases, providing, further opportunities for regulation. Finally, by comparing the flaviviral, proteases with the more distantly related Hepatitis C virus, we provide, insights into the evolution of the Flaviviridae fold. Our work should, expedite the design of protease inhibitors to treat a range of flaviviral, infections.
Pathogenic members of the flavivirus family, including West Nile Virus (WNV) and Dengue Virus (DV), are growing global threats for which there are no specific treatments. The two-component flaviviral enzyme NS2B-NS3 cleaves the viral polyprotein precursor within the host cell, a process that is required for viral replication. Here, we report the crystal structure of WNV NS2B-NS3pro both in a substrate-free form and in complex with the trypsin inhibitor aprotinin/BPTI. We show that aprotinin binds in a substrate-mimetic fashion in which the productive conformation of the protease is fully formed, providing evidence for an "induced fit" mechanism of catalysis and allowing us to rationalize the distinct substrate specificities of WNV and DV proteases. We also show that the NS2B cofactor of WNV can adopt two very distinct conformations and that this is likely to be a general feature of flaviviral proteases, providing further opportunities for regulation. Finally, by comparing the flaviviral proteases with the more distantly related Hepatitis C virus, we provide insights into the evolution of the Flaviviridae fold. Our work should expedite the design of protease inhibitors to treat a range of flaviviral infections.


==About this Structure==
==About this Structure==
Line 15: Line 15:
[[Category: Protein complex]]
[[Category: Protein complex]]
[[Category: West nile virus]]
[[Category: West nile virus]]
[[Category: Aleshin, A.E.]]
[[Category: Aleshin, A E.]]
[[Category: Liddington, R.C.]]
[[Category: Liddington, R C.]]
[[Category: Shiryaev, S.A.]]
[[Category: Shiryaev, S A.]]
[[Category: Strongin, A.Y.]]
[[Category: Strongin, A Y.]]
[[Category: aprotinin]]
[[Category: aprotinin]]
[[Category: bpti]]
[[Category: bpti]]
Line 28: Line 28:
[[Category: west nile virus]]
[[Category: west nile virus]]


''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Jan 23 15:16:24 2008''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 17:53:21 2008''

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA